Molecular Biometrics Attracts Another $12.5 Million
Posted by | February 22, 2010
Molecular Biometrics, Inc., one of Safeguard Scientifics’ Life Sciences partner companies, raised another $12.5 million of capital.
The new capital will support three big goals. First, to accelerate the international launch of ViaMetrics-E™, Molecular’s non-invasive process to improve the success of in vitro fertilizations (IVF). Second, to complete its ongoing FDA clinical study of ViaMetrics-E for domestic markets. Lastly, to meet its manufacturing needs.
James A. Datin, head of our Life Sciences group, believes ViaMetrics-E is well-positioned to penetrate the $4 billion global IVF market. Joining Safeguard in the financing round was new investor Atlas Venture (Waltham, MA), which led the round, with participation from existing investor Oxford Bioscience Partners (Boston, MA).
There is more about Molecular Biometrics and its metabolomics technology on its Web site.
